Successful treatment of paraganglioma with sorafenib: a case report and brief review of the literature

INTRODUCTION: To date, no effective systemic therapies have been made available for paraganglioma. However, multiple mutations in susceptibility genes have been identified that are potential targets for sorafenib, an oral multitargeted tyrosine-kinase inhibitor. CASE PRESENTATION: We report the case...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Yun, Li, Qun, Huang, Wei, Jia, Xinyan, Jiang, Hong, Gao, Yong, Li, Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3821793/
https://www.ncbi.nlm.nih.gov/pubmed/24235841
http://dx.doi.org/10.2147/OTT.S53813

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3821793/
https://www.ncbi.nlm.nih.gov/pubmed/24235841
http://dx.doi.org/10.2147/OTT.S53813

Ejemplares similares